Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification
暂无分享，去创建一个
L. Grimaldi | G. Palù | F. Bandini | L. Barzon | A. Uccelli | G. Mancardi | A. Laroni | V. Militello | M. Sormani | A. Bertolotto | G. Vitello | F. Rinaldi | E. Capello | M. Pizzorno | I. Gandoglia | J. McDermott | O. Varnier | C. Giacomazzi | I. Martini | P. Gallo
[1] H. Hartung,et al. Assessment of JC virus DNA in blood and urine from natalizumab‐treated patients , 2011, Annals of neurology.
[2] K. Simon,et al. Anti‐JC virus antibodies: Implications for PML Risk Stratification , 2010, Annals of neurology.
[3] R. Kinkel,et al. Discrepant findings in immune responses to JC virus in patients receiving natalizumab , 2010, The Lancet Neurology.
[4] D. Clifford,et al. Natalizumab-associated progressive multifocal leukoencephalopathy. , 2012 .
[5] G. Pantaleo,et al. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study , 2010, The Lancet Neurology.
[6] S. Sadiq,et al. JCV detection in multiple sclerosis patients treated with natalizumab , 2010, Journal of Neurology.
[7] L. Ngo,et al. Asymptomatic reactivation of JC virus in patients treated with natalizumab. , 2009, The New England journal of medicine.
[8] J. Lechner-Scott,et al. Parallel Session 13 – Late Breaking News , 2009 .
[9] M. Rugge,et al. Investigation on the presence of polyomavirus, herpesvirus, and papillomavirus sequences in colorectal neoplasms and their association with cancer , 2009, International journal of cancer.
[10] D. Rolla,et al. Kidney graft loss associated with JC polyomavirus nephropathy. , 2009, Journal of nephrology.
[11] S. Atlas,et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. , 2005, The New England journal of medicine.
[12] J. Heritage,et al. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. , 1983, The Journal of infectious diseases.